Clinical Trial Update: Oral vs Intravenous Diltiazem for Rapid Atrial Fibrillation/Flutter Trial [Phase 4]

View source ↗

Summary

Phase 4 trial comparing oral versus intravenous diltiazem for rapid atrial fibrillation/flutter has completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter

Drugs mentioned

• Diltiazem (diltiazem)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Atrial Fibrillation and Flutter | Phase 4 | Status: COMPLETED | Results posted: 2023-03-01